Article Versions Notes

Yin J, Zhao G, Kalirai H, Coupland SE, Jochemsen AG, Forn-Cuní G, Wierenga APA, Jager MJ, Snaar-Jagalska BE, Groenewoud A. Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery. Pharmaceuticals. 2023; 16(4):598. https://doi.org/10.3390/ph16040598

Yin, Jie, Gangyin Zhao, Helen Kalirai, Sarah E. Coupland, Aart G. Jochemsen, Gabriel Forn-Cuní, Annemijn P. A. Wierenga, Martine J. Jager, B. Ewa Snaar-Jagalska, and Arwin Groenewoud. 2023. "Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery" Pharmaceuticals 16, no. 4: 598. https://doi.org/10.3390/ph16040598

Yin, J., Zhao, G., Kalirai, H., Coupland, S. E., Jochemsen, A. G., Forn-Cuní, G., Wierenga, A. P. A., Jager, M. J., Snaar-Jagalska, B. E., & Groenewoud, A. (2023). Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery. Pharmaceuticals, 16(4), 598. https://doi.org/10.3390/ph16040598